Australian owned and managed, BioProspect is one of Australia’s emerging natural compound and product development companies that is conducting research and early-stage commercialisation in the pesticide and agricultural sectors.
Established in 1998 and listed on the Australian Stock Exchange in January 2001, BioProspect aims to be a key international supplier of proven naturally derived compounds and IP for the pesticide and agricultural industries.
BioProspect exists through a desire and capability to satisfy a growing market place that demands safer products that have been proven and registered under internationally recognised practices in order to have an immediate fit in existing distribution channels around the world.